Article
6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation.
The Journal of biological chemistry - 7 Apr 2006
Alves da Costa Cristine, Dunys Julie, Brau Frédéric, Wilk Sherwin, Cappai Roberto, Checler Frédéric
Abstract excerpt
We established previously that alpha-synuclein displayed a protective anti-apoptotic phenotype in neurons, mainly by down-regulating p53-dependent caspase-3 activation (Alves da Costa, C., Ancolio, K., and Checler, F. (2000) J. Biol. Chem. 275, 24065-24069; Alves da Costa, C., Paitel, E., Vincent, B., and Checler, F. (2002) J. Biol. Chem. 277, 50980-50984). This function was abolished by Parkinson disease-linked...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
